Biomarker Predicts Poor Prognosis in African-Americans with Triple-Negative Breast Cancer

ATLANTA—Having high levels of a certain biomarker is linked to poor prognosis in African-American patients with triple-negative breast cancer, while the same biomarker doesn’t influence disease outcomes in white patients, according to a new study.